Literature DB >> 201666

Improved glycine-extracted complement-fixing antigen for human cytomegalovirus.

J D Kettering, N J Schmidt, E H Lennette.   

Abstract

High-titered, sensitive, and stable complement-fixing antigens for human cytomegalovirus were consistently produced from human diploid fibroblast cells infected at a high multiplicity of virus, harvested after 7 days of incubation, and sonically treated immediately in 0.1 M glycine buffer, pH 9.5.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 201666      PMCID： PMC274840          DOI： 10.1128/jcm.6.6.647-649.1977

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  4 in total

1.  Complement-fixing antibody in human sera reactive with viral and soluble antigens of cytomegalovirus.

Authors:  N E Cremer; N J Schmidt; F Jensen; M Hoffman; L S Oshiro; E H Lennette
Journal:  J Clin Microbiol       Date:  1975-03       Impact factor: 5.948

2.  Complement-fixing antigen of human cytomegaloviruses.

Authors:  K S Kim; H M Moon; V J Sapienza; R I Carp
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

3.  Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells.

Authors:  N J Schmidt; J Dennis; E H Lennette
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

4.  A study of complement-fixing, immunofluorescent, and neutralizing antibodies in human cytomegalovirus infections.

Authors:  U Krech; M Jung; W Sonnabend
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1971-06
  4 in total
  21 in total

Review 1.  Herpesviruses.

Authors:  M C Timbury; E Edmond
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

2.  Comparison of enzyme-linked immunosorbent assay (ELISA) technique and complement-fixation test for estimation of cytomegalovirus IgG antibody.

Authors:  J C Booth; G Hannington; T A Aziz; H Stern
Journal:  J Clin Pathol       Date:  1979-02       Impact factor: 3.411

3.  Comparison of serological tests for the detection of antibody to natural and experimental murine cytomegalovirus.

Authors:  G Lussier; D Guénette; J P Descôteaux
Journal:  Can J Vet Res       Date:  1987-04       Impact factor: 1.310

4.  Comparison of four methods for screening of cytomegalovirus antibodies in normal donors and immunocompromised patients.

Authors:  F de Ory; P León; C Domingo; A Garcia-Sáiz; L Pérez; J M Echevarría
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

5.  Antibodies to viruses of the herpes group in glomerulonephritis of membranous, membranoproliferative and IgA types.

Authors:  M Uj; G Szücs; J Nagy; C Trinn
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

6.  Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay.

Authors:  J M Middeldorp; J Jongsma; A ter Haar; J Schirm; T H The
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

7.  Solid-phase enzyme immunoassay for determination of antibodies to cytomegalovirus.

Authors:  R V Krishna; O H Meurman; T Ziegler; U H Krech
Journal:  J Clin Microbiol       Date:  1980-07       Impact factor: 5.948

8.  Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus.

Authors:  D D Erdman; L J Anderson; D R Adams; J A Stewart; L E Markowitz; W J Bellini
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

9.  Enzyme linked immunosorbent assay (ELISA) for the detection of antibodies to porcine cytomegalovirus.

Authors:  R Assaf; A M Bouillant; E Di Franco
Journal:  Can J Comp Med       Date:  1982-04

10.  Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera.

Authors:  L Pereira; M Hoffman; N Cremer
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.